RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Evecxia Therapeutics, Inc. today announced favorable safety, tolerability, pharmacokinetic, and pharmacodynamic data from a double-blind, ...

- Oral EVX-101 administration over 3 months was modeled in rats and pigs co-treated with the first-line antidepressant fluoxetine. - There were no toxicological findings in either species, even at ...